A Phase III, Open-label Study of MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 08 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Feb 2018 According to an Akebia Therapeutics media release, data read-out expected in 2019.
- 09 Jan 2018 New trial record